Our previous studies demonstrated the efficacy of GNP-EGFR in differentiating oral squamous cell carcinoma from less severe lesions, and the current findings extend this potential to salivary gland tumors [9,11,12]. This evidence concerns the gene EGFR and tumor of salivary gland.